Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Acellular antiBortedella vaccine claimed by Institut Pasteur

Aug. 16, 1996

Oxygermylpropionic acid polymer reported by Sanwa Kagaku

Aug. 16, 1996

FDA approves expanded use of Acel-Imune

Aug. 16, 1996

CSL discloses HPV vaccine components

Aug. 16, 1996

Supplementary approval granted for Tripedia

Aug. 16, 1996

Chronic bronchitis patients undergo Pseudostat phase II trials

Aug. 9, 1996

Allotrap 2702 enters second phase II trials

Aug. 9, 1996

Sangstat initiates cyclosporine and azathioprine bioequivalence trials

Aug. 9, 1996

Peptech's PTL-78419 covered under U.S. and European patents

Aug. 9, 1996

SangStat's Thymoglobulin nearing phase III trials completion

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...